CTRI/2020/06/026103进行中(未招募)2 期
Evaluation Of The Immuno-Stimulatory Potential (Shareera Bala) Of An Ayurveda Management Protocol In Cohort Of Dda Resident Of Gautampuri - An Exploratory Clinical Study
试验速览
- 阶段
- 2 期
- 状态
- 进行中(未招募)
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.DDA residents, Gautampuri of either sex aged 19-60 years
- •2.Agrees not to self-medicate with chloroquine, hydroxychloroquine or other potential antivirals.
- •3.Individuals agree to give consent for participation
排除标准
- •1.Individuals with chronic comorbid conditions which has affected the Bala of the Individual.
- •2.Already suffering with severe respiratory allergies and other conditions which may create bias in the outcome results
- •3.Individuals found positive for COVID 19 during the course of medication. Defined as: temperature > 38 Celsius; cough; shortness of breath; sore throat; or, if available (not required), positive confirmatory testing for COVID-19
- •4.Previously diagnosed with COVID-19
- •5.Subjects on other prophylactic medications.
- •6.Concurrent condition that in the investigatorâ??s opinion would jeopardize compliance with the protocol.
研究者
相似试验
尚未招募
2 期
Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical StudyCTRI/2020/05/025178All India Institute of Ayurveda
尚未招募
2 期
Immuno -Modulatory Potential of AyurRaksha Kit and Its Preventive Impact on COVID 19 In Delhi PoliceCTRI/2021/08/035745Ministry of AYUSH
已完成
不适用
A study for evaluating the immunostimulating effect -A Randomized, double-blind, placebo controlled trial.Healthy adults who feel fatigueJPRN-UMIN000021989ORTHOMEDICO, Inc.40
尚未招募
不适用
Screening potential allergy vaccine componentsAllergyNL-OMON24623Investigator initiated- Amsterdam university medical centers50
招募中
不适用
In vitro evaluation of the immune-skewing potential of different candidate building blocks for nanoparticle-based allergen immunotherapy for treatment of allergy*Hypersensitivity10001708AllergyNL-OMON54501Academisch Medisch Centrum80
